A Study on Pharmacokinetics and Safety of BAT2506 Injection Versus Simponi®

NCT05332730 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

375

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriatic Arthritis

Interventions

DRUG: BAT2506 injection
DRUG: Simponi® (EU commercially available product)
DRUG: Simponi® (US commercially available product)

Sponsor

Bio-Thera Solutions

Collaborators

[object Object]